ClinicalTrials.gg
CompletedNCT07411157Updated Feb 13, 2026

Technology-based Distraction Techniques in Managing Children With Attention-deficit/Hyperactivity Disorder

An interventional study of Virtual reality glasses and White noise in Dental Pain, sponsored by Alexandria University. Completed at 1 site in Egypt. Open to participants aged 7 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-02-13.

Sponsored by Alexandria University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 2 years 6 months after the study started (first participant enrolled Jul 2023, registered Jan 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
7 Years to 10 Years
Sex
All
01

Study summary

The present study aims to assess and compare the effectiveness of different technology-based distraction techniques on pain perception and dental anxiety in children with Attention Deficit/Hyperactivity Disorder during different dental procedures

02

Conditions studied

  • Dental Pain

Browse trials for

03

In context

Toothache

142 studies on the registry are indexed under Toothache; 28 are open to participants now.

This study's enrollment of 48 is below the median of 84 across 123 interventional studies indexed under Toothache.

Browse Toothache studies →

Lead sponsor

Alexandria University is the lead sponsor of 604 studies on the registry; 140 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children diagnosed with ADHD according to the criteria and diagnosis confirmed by a pediatric neurologist.
  • All children should be on stimulant medication.
  • No previous dental experience.
  • Written consent of the legal guardian.

Exclusion criteria

Exclusion Criteria:

  • Children with physical disabilities or other psychiatric disorders.
  • Children with visual or hearing disabilities.
  • Patients requiring emergency treatment.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    Virtual reality glasses

    Behavioral: Virtual reality glasses

  • Active comparator
    White noise

    Behavioral: White noise

  • Sham comparator
    Basic behavior management techniques

    Behavioral: Basic behavior management techniques

Interventions

  • BehavioralVirtual reality glasses

    Children allocated to this group were distracted using VR glasses during dental treatment which is an individual headset that has earphones incorporated. Age-appropriate cartoons and movies were shown to the children. The VR glasses were then introduced to the children. The children were given time to accommodate with the device before starting the procedure. The VR glasses were applied during the treatment.

  • BehavioralWhite noise

    Wireless kids' headphones were introduced to the children allocated to this group. They were given some time to accommodate with the headphones. Then, the white noise was played and children were asked to concentrate on the music during the procedure. White noise stimulus was set at 70decibels, within the "normal conversation" volume range and below what is considered harmful to hearing. The white noise of rain sound, managed with an iPhone application called Muse. The decibel level of white noise was calibrated using a portable digital sound level meter

  • BehavioralBasic behavior management techniques

    Children allocated to this group were managed by the basic behavior guidance techniques: (Tell-ShowDo). No adjunctive distraction tool were used.

06

What researchers measure

Primary outcomes

  1. Pain-related behavior

    Children's behavior using the revised Face, Leg, Activity, Cry, Consolability scale (r-FLACC). The r-FLACC scale has been identified as a recommended measurement tool for assessing pain in children aged 0 to 18 years, with a high level of intra- and inter-reliability. Each of the r-FLACC's categories is scored from 0 to 2, which results in a total score between 0 and 10: 0 'relaxed and comfortable'; 1-3 'mild discomfort'; 4-6 'moderate pain'; and 7-10 'severe pain or discomfort or both. The operator assigned a score to each child based on the child's behavior by analysis of the recorded videotape.

    Time frame: The scores were assessed perioperative at 4 procedures: • During needle penetration. • During rubber dam clamp application. • During caries removal. • During placement of composite restoration.

Secondary outcomes

  1. Pulse rate

    The pulse rate was measured using a pulse oximeter. Normal range is considered from 70-110.

    Time frame: The pulse rate was recorded at the baseline and perioperative during needle penetration, rubber dam clamp application, caries removal, placement of composite restoration, and postoperatively after composite finishing and occlusal adjustment.

  2. Self reported pain

    Self-reported pain was measured using the Wong-Baker FACES rating scale using six cartoon faces, from a broad smile (0, "No Hurt") to a tearful frown (10, "Hurts Worst"), to help children indicate their pain level, with scores increasing by twos (0, 2, 4, 6, 8, 10) to represent mild to severe pain.

    Time frame: The scale was administered at the baseline (preoperative) and postoperatively at the end of the visit.

07

Study locations

1 site
  • Pediatric Neurology Outpatient Clinic, Faculty of Medicine, Alexandria University, Egypt
    Alexandria, Alexandria Governorate 21527, Egypt
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2023 to primary completion in Dec 2023, 4 months.

Of 44 non-industry interventional studies with no phase under Toothache, half reached primary completion within 5 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's 4 months is below that.

Counting every sponsor, half of 45 studies reached it within 5 months; a quarter within 3 and three quarters within 12.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 14, 2026
First posted
Feb 13, 2026
StartActual
Jul 10, 2023
Primary completionActual
Dec 1, 2023
CompletionActual
Feb 1, 2024
Last update
Feb 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07411157
Responsible party
Nahla Aly (Assistant Lecturer of Pediatric Dentistry, Alexandria University) — Principal investigator
First posted
Feb 13, 2026
Start date
Jul 10, 2023
Primary completion
Dec 1, 2023
Completion
Feb 1, 2024
Last update
Feb 13, 2026

Study contacts

Nahla A. Aly, MSc
principal investigator · Alexandria University
Amina M. Abdelrahman, PhD
study director · Alexandria University
Karin ML Dowidar, PhD
study chair · Alexandria University
Tarek Omar, PhD
study director · Alexandria University
Nourhan M. Aly, PhD
study director · Alexandria University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion